Is it time to start COVID-19 vaccination in pregnant women?
HIGHLIGHTS 1. Pregnant women infected with COVID 19 have a higher risk of maternal fetal mortality and morbidity. 2. The available evidences show a safety profile in all type of COVID vaccines in pregnancy. 3. Vaccination in pregnant women will decrease pregnancy complications, adverse pregnancy ou...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Airlangga
2021-09-01
|
| Series: | Majalah Obstetri dan Ginekologi |
| Subjects: | |
| Online Access: | https://e-journal.unair.ac.id/MOG/article/view/28863 |
| _version_ | 1818361011815579648 |
|---|---|
| author | Muhammad Ilham Aldika Akbar |
| author_facet | Muhammad Ilham Aldika Akbar |
| author_sort | Muhammad Ilham Aldika Akbar |
| collection | DOAJ |
| description | HIGHLIGHTS
1. Pregnant women infected with COVID 19 have a higher risk of maternal fetal mortality and morbidity.
2. The available evidences show a safety profile in all type of COVID vaccines in pregnancy.
3. Vaccination in pregnant women will decrease pregnancy complications, adverse pregnancy outcomes, and maternal death risk.
4. The benefit of COVID vaccination exceeds the potential risk in pregnant women.
5. Pregnant women are strongly recommended to receive COVID vaccine.
ABSTRACT
COVID-19 pandemic has been lasting for years, and pregnant women encounter an increased risk of mortality and morbidity. Until now, vaccine COVID-19 has been developed and shows a promising result. Unfortunately, pregnant women are consistently excluded from receiving a new vaccine. Because pregnant women are excluded from participating in a clinical trial of vaccines related to safety issues, this exclusion cycle prevents pregnant women from receiving the vaccine that may benefit them. In this review article, the author provides evidence, data, and the reason why vaccination of pregnant women should be started in Indonesia, at least in a clinical trial, especially for health workers and women with comorbidities. |
| first_indexed | 2024-12-13T21:09:54Z |
| format | Article |
| id | doaj.art-685d11f0cda849bea3dbbfc064892c7a |
| institution | Directory Open Access Journal |
| issn | 0854-0381 2598-1013 |
| language | English |
| last_indexed | 2024-12-13T21:09:54Z |
| publishDate | 2021-09-01 |
| publisher | Universitas Airlangga |
| record_format | Article |
| series | Majalah Obstetri dan Ginekologi |
| spelling | doaj.art-685d11f0cda849bea3dbbfc064892c7a2022-12-21T23:31:23ZengUniversitas AirlanggaMajalah Obstetri dan Ginekologi0854-03812598-10132021-09-01292849010.20473/mog.V29I22021.84-9013534Is it time to start COVID-19 vaccination in pregnant women?Muhammad Ilham Aldika Akbar0Department of Obstetrics Gynecology, Faculty of Medicine, Universitas Airlangga, Universitas Airlangga Hospital - Dr. Soetomo General Academic Hospital, SurabayaHIGHLIGHTS 1. Pregnant women infected with COVID 19 have a higher risk of maternal fetal mortality and morbidity. 2. The available evidences show a safety profile in all type of COVID vaccines in pregnancy. 3. Vaccination in pregnant women will decrease pregnancy complications, adverse pregnancy outcomes, and maternal death risk. 4. The benefit of COVID vaccination exceeds the potential risk in pregnant women. 5. Pregnant women are strongly recommended to receive COVID vaccine. ABSTRACT COVID-19 pandemic has been lasting for years, and pregnant women encounter an increased risk of mortality and morbidity. Until now, vaccine COVID-19 has been developed and shows a promising result. Unfortunately, pregnant women are consistently excluded from receiving a new vaccine. Because pregnant women are excluded from participating in a clinical trial of vaccines related to safety issues, this exclusion cycle prevents pregnant women from receiving the vaccine that may benefit them. In this review article, the author provides evidence, data, and the reason why vaccination of pregnant women should be started in Indonesia, at least in a clinical trial, especially for health workers and women with comorbidities.https://e-journal.unair.ac.id/MOG/article/view/28863covid-19vaccinematernal healthinfectious diseasemedicine |
| spellingShingle | Muhammad Ilham Aldika Akbar Is it time to start COVID-19 vaccination in pregnant women? Majalah Obstetri dan Ginekologi covid-19 vaccine maternal health infectious disease medicine |
| title | Is it time to start COVID-19 vaccination in pregnant women? |
| title_full | Is it time to start COVID-19 vaccination in pregnant women? |
| title_fullStr | Is it time to start COVID-19 vaccination in pregnant women? |
| title_full_unstemmed | Is it time to start COVID-19 vaccination in pregnant women? |
| title_short | Is it time to start COVID-19 vaccination in pregnant women? |
| title_sort | is it time to start covid 19 vaccination in pregnant women |
| topic | covid-19 vaccine maternal health infectious disease medicine |
| url | https://e-journal.unair.ac.id/MOG/article/view/28863 |
| work_keys_str_mv | AT muhammadilhamaldikaakbar isittimetostartcovid19vaccinationinpregnantwomen |